HR

Hanspeter Rottensteiner

BI Baxalta Incorporated: 17 patents #6 of 230Top 3%
TL Takeda Pharmaceutical Company Limited: 11 patents #122 of 1,531Top 8%
BS Baxter Healthcare Sa: 6 patents #159 of 1,132Top 15%
BI Baxter International: 6 patents #326 of 2,334Top 15%
LL Lipoxen Technologies Limited: 2 patents #10 of 23Top 45%
NT Nektar Therapeutics: 1 patents #159 of 250Top 65%
📍 Wien, AT: #28 of 3,624 inventorsTop 1%
Overall (All Time): #101,860 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 26–34 of 34 patents

Patent #TitleCo-InventorsDate
9488651 Methods of measuring ADAMTS 13 activity Katalin Varadi, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2016-11-08
9274122 Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) Katalin Varadi, Gerald Schrenk, Peter Turecek, Alfred Weber, Heinz Anderle +5 more 2016-03-01
9110085 Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor Katalin Varadi, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2015-08-18
8945897 Materials and methods for conjugating a water soluble fatty acid derivative to a protein Juergen Siekmann, Richard Sheinecker, Peter Turecek 2015-02-03
8809501 Nucleophilic catalysts for oxime linkage Juergen Siekmann, Stefan Haider, Peter Turecek 2014-08-19
8642737 Nucleophilic catalysts for oxime linkage Juergen Siekmann, Stefan Haider, Andreas Ivens, Peter Turecek, Oliver Zoechling 2014-02-04
8637640 Blood coagulation protein conjugates Juergen Siekmann, Stefan Haider, Peter Turecek 2014-01-28
8623612 Method for testing treatment of ADAMTS13 deficiency Katalin Varadi, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2014-01-07
8415114 Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereof Katalin Varadi, Peter Turecek, Hans-Peter Schwarz, Jutta Schreiner 2013-04-09